Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd > Twitter !
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(31)
•••
Comment by TheTerminator1on Apr 15, 2021 5:09pm
35 Views
Post# 33005378

RE:RE:RE:RE:Twitter !

RE:RE:RE:RE:Twitter !You are and will always be a scumbag and i don't like scumbags!!!

How many puppets will you be using in the coming days,weeks and months to promote your agenda!!!

1ottrunner wrote: Might we start having a mature conversation Ricky?

Idiot.

By the way, the poster of that tweet?  He is one of those that gave their name the second time they dialed in this week.  After realizing how disruptive it was to do so he still couldn't pass up the chance to have us hear his name the second time.

I believe I heard MF groan when his name was announced...again.


TheTerminator1 wrote: Will you stop whining!

1ottrunner wrote:


Now all we have to do is wait another 60 - 220 days to trial endpoints.  Then another 60 - 90 days to collect and submit the data.

Just after that we only need to await the FDA to review it!!!!

ALMOST THERE FOLKS!

 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities